Singapore Pharmaceutical Industry Report - H2, 2012

USD $449.00
Singapore Pharmaceutical Industry Report - H2, 2012

Over the last decade, Singapore has established itself as the manufacturing hub for leading pharmaceutical companies in Asia. The country’s manufacturing output of pharmaceuticals and biological products grew at an impressive compounded annual growth rate (CAGR) of 15.8% over the 10-year period from 2001 to 2011. During the same period, the economic environment in Singapore had an average GDP growth rate of 6.3% per year.

The report includes the market trends and outlook of the pharmaceutical industry in Singapore. We examine the exports and imports of pharmaceutical products, key economic indicators, production index, value-added by sector, human resources, cost of operation, capital expenditure and government initiatives. Pharmaceutical sector contributed approximately 19.3% to the overall value added of the manufacturing industries. The sector only trailed electronic products sector in terms of value addition.

Also, the report encompasses the profile of leading players in the pharmaceutical industry as well as their respective financial highlights and SWOT analysis. Among the leading pharmaceutical players in Singapore are Luye Pharma Group Limited, Star Pharmaceuticals Limited and Pharmesis International Limited.

Key Points:

• The total output of pharmaceuticals and biological products in Singapore surged 20.1% year on year in 2011.

• Pharmaceutical sector contributed approximately 19.3% to the overall value added to manufacturing industries.

• At the end of the fourth quarter of FY2012, the pharmaceutical manufacturing index grew by a marginal rate of 1.1% year on year.

Table of Contents

1. Industry Profile
1.1 Sector Overview
1.2 Sector Size
1.3 Competitive Landscape
1.4 Environmental Scanning
1.5 Recent Developments in the Industry

2. Market Trends and Outlook
2.1 Key Economic Indicators
2.2 Production Index
2.3 Export and import
2.4 Value Added by the Sector
2.5 Human Resources
2.6 Cost of Operation
2.7 Capital Expenditure
2.8 Government Initiatives

3. Leading Players and Comparative Matrix
3.1 Leading Players
3.1.1 Luye Pharma Group Limited
3.1.2 Star Pharmaceuticals Limited
3.1.3 Pharmesis International Limited
3.2 Comparative Matrix
3.3 SWOT Analysis

4. Tables and Charts

Table 1: Research Initiatives undertaken in Singapore by Different Organizations
Table 2: Key Highlights of Good Manufacturing Practice (GMP) Standards for
Medicinal Products
Table 3: General Economic Statistics
Table 4: Subsidiaries of Luye Pharma
Table 5: Luye Pharma Financial Highlights in 2Q2012
Table 6: Research Collaborations of Star Pharmaceuticals Limited with Institutes
Table 7: Products of Pharmesis
Table 8: Financial Highlights of the Leading Players

Chart 1: Manufacturing Output of Pharmaceuticals & Biological Products in
Chart 2: Top Exporters of Medicinal and Pharmaceutical Products in 2011
Chart 3: Total Output of Pharmaceuticals and Biological Products
Chart 4: Constituent Parties in Parliament (After General Election 2011)
Chart 5: Cost of Business Start-up Procedures (% of GNI per Capita)
Chart 6: Pharmaceutical Research Workforce of Singapore
Chart 7: Singapore Quarterly GDP Growth Rate YoY Change)
Chart 8: Growth in External Trade of Singapore (YoY Change)
Chart 9: Sectoral Growth Rates in 2012
Chart 10: Index of Industrial Production (2011=100)
Chart 11: Index of Industrial Production - Growth Rate
Chart 12: Export of Medicinal and Pharmaceuticals Products
Chart 13: Breakdown of Exports of Medicinal and Pharmaceutical Products
Chart 14: Imports of Medicinal and Pharmaceuticals Products
Chart 15: Value Added of Manufacturing Industries in 2011
Chart 16: Annual Value Added by Pharmaceutical Sector
Chart 17: Number of Workers in Pharmaceutical Manufacturing Sector
Chart 18: Average Annual Remuneration per Worker
Chart 19: Breakup of Cost of Operation in Pharmaceutical Sector in 2011
Chart 20: Operating Margins in Different Manufacturing Sectors in 2010
Chart 21: Breakup of Capital Expenditure by Manufacturing Industries of Singapore
Chart 22: Annual Capital Expenditure in Pharmaceutical Sector
Chart 23: Segmental Revenues of Luye Pharma in FY2011
Chart 24: Luye Pharma Financial Highlights
Chart 25: Segmental Revenues of Star Pharmaceuticals in FY2012
Chart 26: Star Pharmaceuticals Financial Highlights
Chart 27: Segmental Revenues of Pharmesis in FY 2012
Chart 28: Pharmesis Financial Highlights

Number of pages: 30
Release Date: Wed, 20 Mar 2013